AR065989A1 - Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno - Google Patents
Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el suenoInfo
- Publication number
- AR065989A1 AR065989A1 ARP080101456A ARP080101456A AR065989A1 AR 065989 A1 AR065989 A1 AR 065989A1 AR P080101456 A ARP080101456 A AR P080101456A AR P080101456 A ARP080101456 A AR P080101456A AR 065989 A1 AR065989 A1 AR 065989A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- methods
- agent
- sound
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Métodos para el tratamiento de un trastorno de la respiracion relacionado con el sueno tal como la apnea del sueno obstructiva, que comprende la administracion de O-desmetilvenlafaxina o duloxetina. Reivindicacion 5: El método de acuerdo con lareivindicacion 1, caracterizado porque la O-desmetilvenlafaxina es administrada en forma conjunta con un segundo agente activo, en el que el mencionado segundo agente activo es un mejorador del sueno, un agente que trata la excesiva somnolenciadurante las horas del día, un agente contra la obesidad, o un agente que estabiliza el impulso respiratorio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92246607P | 2007-04-09 | 2007-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065989A1 true AR065989A1 (es) | 2009-07-15 |
Family
ID=39831524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080101456A AR065989A1 (es) | 2007-04-09 | 2008-04-08 | Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno |
Country Status (15)
Country | Link |
---|---|
US (3) | US20080293823A1 (es) |
EP (2) | EP2142183A2 (es) |
JP (1) | JP2010523662A (es) |
KR (1) | KR20100015923A (es) |
CN (1) | CN101686955A (es) |
AR (1) | AR065989A1 (es) |
AU (1) | AU2008236624A1 (es) |
BR (1) | BRPI0810159A2 (es) |
CA (1) | CA2683697C (es) |
IL (1) | IL201430A0 (es) |
MX (1) | MX2009010805A (es) |
NZ (1) | NZ580250A (es) |
RU (1) | RU2009141168A (es) |
TW (1) | TW200901956A (es) |
WO (1) | WO2008124128A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120101588A (ko) * | 2010-01-07 | 2012-09-13 | 비버스 인크. | 탄산탈수효소 억제제 및 추가적인 활성제의 조합에 의한 폐쇄 수면 무호흡 증후군의 치료 |
WO2011155797A2 (ko) * | 2010-06-10 | 2011-12-15 | 동아제약 주식회사 | 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물 |
US11911351B2 (en) | 2018-01-30 | 2024-02-27 | Apnimed, Inc. (Delaware) | Methods for treating sleep apnea with combinations of atomoxetine and (R)-oxybutynin |
MX2021009407A (es) * | 2019-02-08 | 2021-09-10 | Brigham & Womens Hospital Inc | Métodos y composiciones para el tratamiento de la apnea del sueño. |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
US5803066A (en) * | 1992-05-07 | 1998-09-08 | New York University | Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea |
GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
US6150396A (en) * | 1997-03-07 | 2000-11-21 | Eli Lilly And Company | Methods of treating or preventing interstitial cystitis |
WO1999038504A1 (en) | 1998-01-29 | 1999-08-05 | Sepracor Inc. | Pharmaceutical uses of optically pure (-)-bupropion |
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
DK1466889T3 (da) * | 1999-04-06 | 2008-09-08 | Sepracor Inc | O-Desmethylvenlafaxin-succinat |
WO2000076955A1 (en) * | 1999-06-15 | 2000-12-21 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
CA2556450C (en) * | 2004-02-17 | 2013-08-06 | Transoral Pharmaceuticals, Inc. | Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
US20060039867A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders with setiptiline |
CA2590802A1 (en) * | 2004-12-20 | 2006-06-29 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
JP5197361B2 (ja) * | 2005-06-06 | 2013-05-15 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | 睡眠障害を処置するための組成物および方法 |
WO2007026219A2 (en) * | 2005-08-31 | 2007-03-08 | Pfizer Products Inc. | Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
BRPI0807604A2 (pt) * | 2007-02-21 | 2014-07-22 | Sepracor Inc | Composto, composição farmacêutica, e, métodos para tratar, prevenir ou controlar deprressão, dor, ansiedade, e incontiência |
US20090048233A1 (en) * | 2007-08-16 | 2009-02-19 | Cypress Biosciences, Inc. | Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
-
2008
- 2008-04-08 EP EP08742623A patent/EP2142183A2/en not_active Withdrawn
- 2008-04-08 NZ NZ580250A patent/NZ580250A/en not_active IP Right Cessation
- 2008-04-08 MX MX2009010805A patent/MX2009010805A/es not_active Application Discontinuation
- 2008-04-08 RU RU2009141168/15A patent/RU2009141168A/ru not_active Application Discontinuation
- 2008-04-08 KR KR1020097022364A patent/KR20100015923A/ko not_active Application Discontinuation
- 2008-04-08 CN CN200880018706A patent/CN101686955A/zh active Pending
- 2008-04-08 AR ARP080101456A patent/AR065989A1/es unknown
- 2008-04-08 CA CA2683697A patent/CA2683697C/en not_active Expired - Fee Related
- 2008-04-08 JP JP2010503031A patent/JP2010523662A/ja active Pending
- 2008-04-08 BR BRPI0810159-0A2A patent/BRPI0810159A2/pt not_active Application Discontinuation
- 2008-04-08 AU AU2008236624A patent/AU2008236624A1/en not_active Abandoned
- 2008-04-08 WO PCT/US2008/004508 patent/WO2008124128A2/en active Application Filing
- 2008-04-08 EP EP12154458A patent/EP2455076A1/en not_active Withdrawn
- 2008-04-09 TW TW097112888A patent/TW200901956A/zh unknown
- 2008-04-09 US US12/100,382 patent/US20080293823A1/en not_active Abandoned
-
2009
- 2009-10-11 IL IL201430A patent/IL201430A0/en unknown
-
2012
- 2012-05-25 US US13/481,597 patent/US20120238616A1/en not_active Abandoned
-
2015
- 2015-03-27 US US14/670,523 patent/US20150196531A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2142183A2 (en) | 2010-01-13 |
AU2008236624A1 (en) | 2008-10-16 |
RU2009141168A (ru) | 2011-05-20 |
CA2683697C (en) | 2016-08-16 |
EP2455076A1 (en) | 2012-05-23 |
US20080293823A1 (en) | 2008-11-27 |
WO2008124128A2 (en) | 2008-10-16 |
US20150196531A1 (en) | 2015-07-16 |
CA2683697A1 (en) | 2008-10-16 |
WO2008124128A3 (en) | 2009-05-07 |
TW200901956A (en) | 2009-01-16 |
IL201430A0 (en) | 2010-05-31 |
BRPI0810159A2 (pt) | 2014-12-30 |
NZ580250A (en) | 2012-05-25 |
KR20100015923A (ko) | 2010-02-12 |
US20120238616A1 (en) | 2012-09-20 |
MX2009010805A (es) | 2009-10-29 |
JP2010523662A (ja) | 2010-07-15 |
CN101686955A (zh) | 2010-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20227366B (en) | Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders | |
MX2022010349A (es) | Metodos y composiciones para el tratamiento de apnea del sue?o. | |
GB2491328A (en) | Immediate/delayed drug delivery | |
BRPI0507224A (pt) | método e dispositivo para o tratamento da apnéia obstrutiva do sono e do ronco | |
MY160894A (en) | Oligosaccharide composition for treating skin diseases | |
IL201479A (en) | Use of tapentadol for the preparation of pain medication | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
HK1167641A1 (en) | 4-hydroxybutyric acid analogs 4- | |
GB2491327A (en) | Delayed prolonged drug delivery | |
MX2013004699A (es) | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos. | |
BRPI0509210A (pt) | uso de gaboxadol, e, métodos para tratar função respiratória enfraquecida, e apnéia do sono | |
TW200719882A (en) | Treatment of connective tissue diseases of the skin | |
MX2012007813A (es) | Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional. | |
MX2020008086A (es) | Metodos y composiciones para tratar la apnea del sue?o. | |
NZ582284A (en) | Carbamoyl-cyclohexanes for treating acute mania | |
AR065989A1 (es) | Metodos y composiciones para el tratamiento de trastornos de la respiracion relacionados con el sueno | |
NZ607900A (en) | Compound composition for inhalation used for treating asthma | |
MY167553A (en) | Layered soft palate support and implantation method | |
JP2010523662A5 (es) | ||
BR112014030699A2 (pt) | implante de deformação de língua | |
AR048460A1 (es) | Tratamiento de la funcion respiratoria alterada con gaboxadol | |
MX2009003676A (es) | Compuestos s-nitrosotiol y derivados relacionados. | |
CN201969076U (zh) | 带壳聚糖的改性聚乳酸抗粘连生物膜 | |
ZA201307808B (en) | Nose tensioner and opener and nose tip lifter fir the treatment of obstructive sleep apnoea, snoring and respiratory obstruction | |
BR112015023362A2 (pt) | implante para tratar distúrbios obstrutivos de vias aéreas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |